| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-17 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-17 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-13 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-12 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-09 |